João Pedro Ferreira Selected Research

Atrial Fibrillation

12/2023	Effects of empagliflozin on collagen biomarkers in patients with heart failure: Findings from the EMPEROR trials.
1/2023	External validation and extension of the TIMI risk score for heart failure in diabetes for patients with recent acute coronary syndrome: An analysis of the EXAMINE trial.
1/2023	Empagliflozin in heart failure with preserved ejection fraction with and without atrial fibrillation.
4/2022	Weight changes in heart failure with preserved ejection fraction: findings from TOPCAT.
7/2021	Multi-proteomic approach to predict specific cardiovascular events in patients with diabetes and myocardial infarction: findings from the EXAMINE trial.
1/2021	Prediction of heart failure outcomes in patients with type 2 diabetes mellitus: Validation of the Thrombolysis in Myocardial Infarction Risk Score for Heart Failure in Diabetes (TRS-HFDM ) in patients in the ACCORD trial.
11/2020	Timing of randomization after an acute coronary syndrome in patients with type 2 diabetes mellitus.
1/2020	Predictors of sudden cardiac death in high-risk patients following a myocardial infarction.
1/2020	Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof-of-concept, randomised, precision-medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial.
11/2019	Eplerenone in patients with myocardial infarction and "mid-range" ejection fraction: An analysis from the EPHESUS trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

João Pedro Ferreira Research Topics

Disease

181	Heart Failure 05/2024 - 10/2013
31	Myocardial Infarction 12/2023 - 02/2017
20	Fibrosis (Cirrhosis) 03/2024 - 01/2018
20	Type 2 Diabetes Mellitus (MODY) 03/2024 - 01/2020
15	Stroke (Strokes) 12/2023 - 08/2016
13	Inflammation (Inflammations) 01/2024 - 01/2019
12	Hypertension (High Blood Pressure) 12/2022 - 10/2017
11	Atrial Fibrillation 12/2023 - 08/2016
9	Cardiomyopathies (Cardiomyopathy) 04/2024 - 01/2016
9	Chronic Renal Insufficiency 03/2024 - 11/2016
9	Left Ventricular Dysfunction 04/2022 - 01/2018
8	Coronary Artery Disease (Coronary Atherosclerosis) 12/2023 - 05/2017
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2018
7	Acute Coronary Syndrome 11/2023 - 01/2018
7	Hyperkalemia 01/2023 - 01/2018
6	Respiratory Sounds (Crackle) 11/2022 - 05/2019
5	Diabetes Mellitus 12/2022 - 05/2017
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2024 - 01/2020
4	Chronic Kidney Failure (Chronic Renal Failure) 01/2024 - 01/2017
4	Body Weight (Weight, Body) 07/2023 - 04/2022
4	Obesity 07/2023 - 01/2020
4	Albuminuria 11/2022 - 03/2014
4	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2022 - 11/2019
4	Hemorrhage 01/2021 - 08/2016
4	Hypotension (Low Blood Pressure) 01/2021 - 01/2020
3	COVID-19 03/2024 - 02/2021
3	Necrosis 11/2023 - 01/2022
3	ST Elevation Myocardial Infarction 10/2023 - 01/2018
3	Hypokalemia 01/2023 - 01/2020
3	Gout 01/2023 - 01/2022
3	Acute Kidney Injury (Acute Renal Failure) 01/2023 - 02/2021
3	Anemia 11/2022 - 01/2018
3	Prediabetic State (Prediabetes) 01/2022 - 01/2021
3	Systolic Heart Failure 01/2021 - 01/2018
3	Renal Insufficiency (Renal Failure) 01/2021 - 01/2019
2	Dyspnea (Shortness of Breath) 01/2024 - 09/2023
2	Atherosclerosis 01/2024 - 01/2019
2	Vascular Diseases (Vascular Disease) 10/2023 - 01/2021
2	Overweight 07/2023 - 01/2022
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2023 - 05/2019
2	Weight Loss (Weight Reduction) 01/2023 - 04/2022
2	Hyperuricemia 01/2023 - 01/2022
2	Sudden Death 10/2022 - 11/2020
2	Neoplasms (Cancer) 01/2022 - 01/2019
2	Isolated Systolic Hypertension 11/2021 - 07/2021

Drug/Important Bio-Agent (IBA)

57	empagliflozinIBA 04/2024 - 01/2019
36	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2014
30	Spironolactone (Aldactone)FDA LinkGeneric 03/2024 - 03/2014
21	Brain Natriuretic Peptide (Natrecor)FDA Link 03/2024 - 03/2014
21	Mineralocorticoid Receptor AntagonistsIBA 11/2023 - 01/2014
21	Eplerenone (Inspra)FDA LinkGeneric 01/2023 - 01/2018
16	SodiumIBA 12/2023 - 06/2016
16	Natriuretic PeptidesIBA 12/2023 - 12/2016
15	CreatinineIBA 01/2023 - 11/2016
14	Sodium-Glucose Transport ProteinsIBA 04/2024 - 01/2021
12	pro-brain natriuretic peptide (1-76)IBA 03/2024 - 01/2018
12	Sodium-Glucose Transporter 2 InhibitorsIBA 12/2023 - 01/2020
12	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 01/2020
12	DiureticsIBA 06/2023 - 10/2013
11	PotassiumIBA 01/2023 - 01/2018
10	CollagenIBA 05/2024 - 01/2018
10	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2019
10	AlbuminsIBA 01/2023 - 01/2018
9	Glucagon-Like Peptide-1 Receptor AgonistsIBA 08/2023 - 01/2022
8	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2023 - 01/2019
6	Insulin (Novolin)FDA Link 04/2024 - 04/2019
6	Troponin T (Troponin T1)IBA 12/2023 - 01/2014
6	Uric Acid (Urate)IBA 01/2023 - 10/2020
6	Procollagen Type IIBA 01/2023 - 01/2019
5	SymportersIBA 12/2023 - 01/2021
5	RivaroxabanIBA 12/2023 - 11/2019
5	procollagen type I carboxy terminal peptide (PICP)IBA 12/2023 - 01/2019
5	Hemoglobins (Hemoglobin)IBA 01/2023 - 04/2016
5	TroponinIBA 11/2022 - 01/2014
5	Angiotensin Receptor AntagonistsIBA 11/2022 - 01/2019
5	alogliptinIBA 07/2021 - 01/2020
4	AldosteroneIBA 10/2023 - 01/2018
4	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2023 - 01/2020
4	Losartan (Cozaar)FDA LinkGeneric 01/2023 - 01/2018
4	Collagen Type I (Type I Collagen)IBA 01/2023 - 01/2021
4	procollagen Type III-N-terminal peptide (PIIP)IBA 01/2022 - 01/2019
4	Collagen Type III (Type III Collagen)IBA 01/2022 - 01/2019
4	Antihypertensive Agents (Antihypertensives)IBA 11/2021 - 05/2017
4	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2021 - 01/2020
4	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2020 - 06/2016
3	C-Reactive ProteinIBA 01/2024 - 01/2022
3	omega-Chloroacetophenone (Mace)IBA 01/2024 - 02/2021
3	Glucagon-Like Peptide 1 (GLP 1)IBA 07/2023 - 01/2022
3	dapagliflozinIBA 01/2023 - 01/2020
3	Neprilysin (Neutral Endopeptidase)IBA 01/2023 - 01/2020
3	Valsartan (Vals)FDA Link 01/2021 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2024 - 11/2023
2	fibrin fragment D (D-dimer)IBA 12/2023 - 01/2021
2	Growth Differentiation Factor 15IBA 11/2023 - 01/2020
2	AdrenomedullinIBA 11/2023 - 01/2021
2	rGLP-1 proteinIBA 01/2023 - 10/2022
2	Hormones (Hormone)IBA 01/2023 - 11/2022
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2022 - 07/2021

Therapy/Procedure

50	Therapeutics 11/2023 - 10/2013
2	Patient Readmission 01/2023 - 01/2020